SHERRY TAYLOR: Open Payments
NPI 1952902827 · CANA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 42 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $214 · 2025 $643
Food & beverage: $643
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $225 |
| Vanda Pharmaceuticals Inc. | 5 | $106 |
| AstraZeneca Pharmaceuticals LP | 5 | $99 |
| PFIZER INC. | 5 | $82 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Abbott Laboratories | 1 | $21 |
| Novo Nordisk Inc | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
Products named: VRAYLAR, NURTEC ODT, AIRSUPRA, HETLIOZ, FANAPT, REXULTI, QULIPTA, UBRELVY.
Industry payments across VA — which companies pay providers there.
